Andere talen Peak Bio, Inc.

Aandelen

PKBO

US70470P1084

Beurs gesloten - OTC Markets Andere beurzen 16:39:07 25-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,0096 ^USD	+11,63%		+11,63%	-94,88%

25/06	Peak Bio, Inc. rapporteert de resultaten voor het derde kwartaal en de negen maanden eindigend op 30 september 2023	CI
2023	Peak Bio, Inc. Benoemt Michael Friedman tot lid van de Raad van Bestuur en lid van het Auditcomité en het Vergoedingscomité	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Peak Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	25/06
Akari Therapeutics Announces Interim CEO Employment Contract Demonstrating Alignment with Shareholders	06/06
Peak Bio, Inc. announced that it has received $1.3245 million in funding	28/05
Akari Therapeutics, Plc entered into a definitive agreement to acquire Peak Bio, Inc..	05/03
Peak Bio, Inc. announced that it has received $2.238 million in funding	16/02
Peak Bio, Inc. Receives Loan in the Principal Amount of $750,000	29/01
Peak Bio, Inc. announced that it has received $0.075 million in funding	23/01
Peak Bio, Inc. Awarded Patent with Broad Coverage for Thailanstatin-ADC platform technology (PH-1) a Payload with Novel Immunomodulatory Effects that Target RNA Splicing	04/01
Peak Bio, Inc. announced a financing transaction	18/12
Peak Bio : Private Placement - Form 8-K	02/11
Peak Bio, Inc. Announces Filing of Provisional Patent Applications for PH-1, a Novel and Specific Immunomodulatory ADC payload platform targeting RNA splicing	19-09-23
Peak Bio, Inc. Announces Up-listing to OTCQB Market	31-08-23
Peak Bio, Inc. Announces Up-listing to OTCQB Market	31-08-23
Peak Bio, Inc. Appoints Michael Friedman to Board of Directors and Member of Audit Committee and Compensation Committee	31-08-23
Peak Bio, Inc., Announces Appointment of Michael Friedman to Board of Directors	31-08-23
Peak Bio, Inc., Announces Appointment of Michael Friedman to Board of Directors	31-08-23
Peak Bio, Inc. Announces its Application to Uplist to the OTCQB Venture Market	29-08-23
Peak Bio, Inc. Announces its Application to Uplist to the OTCQB Venture Market	29-08-23
Peak Bio, Inc. Announces Amendment and Continued Access to Equity Line of up to $100 Million USD via an Accelerated Common Stock Purchase Transaction with White Lion Capital	24-08-23
Peak Bio, Inc. announced that it expects to receive $100 million in funding from White Lion Capital Llc	24-08-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Peak Bio, Inc.

Aandelen

PKBO

US70470P1084

Andere talen

Filters